Sathyapalan, Thozhukat <br/><br/>
Metformin maintains the weight loss and metabolic benefits following rimonabant treatment in obese women with polycystic ovary syndrome (PCOS).  [electronic resource] 

 -  Clinical endocrinology  Jan 2009 
 - 124-8 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1365-2265 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2265.2008.03345.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Androgens--blood<br/>Female<br/>Humans<br/>Insulin Resistance<br/>Metformin--therapeutic use<br/>Piperidines--therapeutic use<br/>Polycystic Ovary Syndrome--drug therapy<br/>Pyrazoles--therapeutic use<br/>Rimonabant<br/>Testosterone--blood<br/>Weight Loss--drug effects